- Report
- August 2022
- 117 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- April 2023
- 147 Pages
Global
From €4520EUR$4,949USD£3,865GBP
- Report
- April 2023
- 115 Pages
Global
From €4338EUR$4,750USD£3,710GBP
- Report
- February 2023
- 118 Pages
From €3151EUR$3,450USD£2,694GBP
- Report
- February 2023
- 111 Pages
North America
From €3151EUR$3,450USD£2,694GBP
- Report
- February 2023
- 107 Pages
Africa, Middle East
From €3151EUR$3,450USD£2,694GBP
- Report
- February 2023
- 126 Pages
Europe
From €3151EUR$3,450USD£2,694GBP
- Report
- February 2023
- 135 Pages
Asia Pacific
From €3151EUR$3,450USD£2,694GBP
- Report
- December 2022
- 190 Pages
Global
From €4064EUR$4,450USD£3,476GBP
- Report
- December 2021
- 40 Pages
Saudi Arabia
From €1370EUR$1,500USD£1,172GBP
- Report
- December 2021
- 40 Pages
India
From €1370EUR$1,500USD£1,172GBP
- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2694EUR$2,950USD£2,304GBP
- Report
- September 2023
- 89 Pages
From €2694EUR$2,950USD£2,304GBP
- Report
- September 2023
- 112 Pages
Europe
From €3151EUR$3,450USD£2,694GBP
- Report
- November 2023
- 112 Pages
Global
From €3500EUR$4,105USD£3,098GBP
- Report
- December 2021
- 80 Pages
Africa
From €1827EUR$2,000USD£1,562GBP
- Report
- December 2021
- 40 Pages
Vietnam
From €1370EUR$1,500USD£1,172GBP
- Report
- December 2021
- 40 Pages
United States
From €1370EUR$1,500USD£1,172GBP
- Report
- December 2021
- 40 Pages
South Korea
From €1370EUR$1,500USD£1,172GBP
- Report
- December 2021
- 40 Pages
Russia
From €1370EUR$1,500USD£1,172GBP

The Oral Vaccine market is a subset of the larger Vaccines market, which is focused on the development and distribution of vaccines to prevent and treat infectious diseases. Oral Vaccines are administered orally, rather than through injection, and are typically used to protect against gastrointestinal infections. These vaccines are often used in developing countries, where access to injection-based vaccines may be limited. Oral Vaccines are also used in certain circumstances where injection-based vaccines may not be suitable, such as in the elderly or immunocompromised individuals.
Oral Vaccines are typically composed of weakened or killed pathogens, which stimulate the body’s immune system to produce antibodies against the disease. These vaccines are typically administered in multiple doses, and may require booster shots to maintain immunity.
Some companies in the Oral Vaccine market include GlaxoSmithKline, Merck, Sanofi, Pfizer, and Johnson & Johnson. Show Less Read more